Literature DB >> 28242209

Features of Patients With Hereditary Mixed Polyposis Syndrome Caused by Duplication of GREM1 and Implications for Screening and Surveillance.

Sari Lieberman1, Tom Walsh2, Menachem Schechter3, Tomer Adar3, Eran Goldin3, Rachel Beeri1, Nitzan Sharon4, Hagit Baris4, Liat Ben Avi5, Elizabeth Half6, Israela Lerer5, Brian H Shirts7, Colin C Pritchard7, Ian Tomlinson8, Mary-Claire King2, Ephrat Levy-Lahad9, Tamar Peretz10, Yael Goldberg11.   

Abstract

Hereditary mixed polyposis syndrome is a rare colon cancer predisposition syndrome caused by a duplication of a noncoding sequence near the gremlin 1, DAN family BMP antagonist gene (GREM1) originally described in Ashkenazi Jews. Few families with GREM1 duplications have been described, so there are many questions about detection and management. We report 4 extended families with the duplication near GREM1 previously found in Ashkenazi Jews; 3 families were identified at cancer genetic clinics in Israel and 1 family was identified in a cohort of patients with familial colorectal cancer. Their clinical features include extracolonic tumors, onset of polyps in adolescence, and rapid progression of some polyps to advanced adenomas. One family met diagnostic criteria for Lynch syndrome. Expansion of the hereditary mixed polyposis syndrome phenotype can inform surveillance strategies for carriers of GREM1 duplications.
Copyright © 2017 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CRC; Colon Cancer Susceptibility; HMPS1; Polyposis

Mesh:

Substances:

Year:  2017        PMID: 28242209     DOI: 10.1053/j.gastro.2017.02.014

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  8 in total

1.  Identification of a novel GREM1 duplication in a patient with multiple colon polyps.

Authors:  Danielle B McKenna; Jeroen Van Den Akker; Alicia Y Zhou; Lauren Ryan; Annette Leon; Robert O'Connor; Payal D Shah; Anil K Rustgi; Bryson W Katona
Journal:  Fam Cancer       Date:  2019-01       Impact factor: 2.375

2.  Gastrointestinal Polyposis in Pediatric Patients.

Authors:  Suzanne P MacFarland; Kristin Zelley; Bryson W Katona; Benjamin J Wilkins; Garrett M Brodeur; Petar Mamula
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-09       Impact factor: 2.839

Review 3.  How many is too many? Polyposis syndromes and what to do next.

Authors:  Nina Gupta; Christine Drogan; Sonia S Kupfer
Journal:  Curr Opin Gastroenterol       Date:  2022-01-01       Impact factor: 3.287

4.  Filling the gap: A thorough investigation for the genetic diagnosis of unsolved polyposis patients with monoallelic MUTYH pathogenic variants.

Authors:  Anastasia Dell'Elice; Giulia Cini; Mara Fornasarig; Franco Armelao; Daniela Barana; Francesca Bianchi; Guido Claudio Casalis Cavalchini; Antonella Maffè; Isabella Mammi; Monica Pedroni; Antonio Percesepe; Italo Sorrentini; Mariagrazia Tibiletti; Roberta Maestro; Michele Quaia; Alessandra Viel
Journal:  Mol Genet Genomic Med       Date:  2021-10-26       Impact factor: 2.183

Review 5.  Insights into the Role of Gremlin-1, a Bone Morphogenic Protein Antagonist, in Cancer Initiation and Progression.

Authors:  Noha Mousaad Elemam; Abdullah Imadeddin Malek; Esraa Elaraby Mahmoud; Waseem El-Huneidi; Iman M Talaat
Journal:  Biomedicines       Date:  2022-01-28

Review 6.  Extracellular Nucleic Acids in the Diagnosis and Progression of Colorectal Cancer.

Authors:  Jakub Styk; Gergely Buglyó; Ondrej Pös; Ádám Csók; Beáta Soltész; Peter Lukasz; Vanda Repiská; Bálint Nagy; Tomáš Szemes
Journal:  Cancers (Basel)       Date:  2022-07-29       Impact factor: 6.575

Review 7.  The Inherited and Familial Component of Early-Onset Colorectal Cancer.

Authors:  Maria Daca Alvarez; Isabel Quintana; Mariona Terradas; Pilar Mur; Francesc Balaguer; Laura Valle
Journal:  Cells       Date:  2021-03-23       Impact factor: 6.600

8.  Bone Morphogenetic Protein Antagonist Gremlin-1 Increases Myofibroblast Transition in Dermal Fibroblasts: Implications for Systemic Sclerosis.

Authors:  Laura Duffy; John Henderson; Max Brown; Stefan Pryzborski; Nicola Fullard; Lena Summa; Jorg H W Distler; Richard Stratton; Steven O'Reilly
Journal:  Front Cell Dev Biol       Date:  2021-06-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.